Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

Stephen P. Arneric; David J. Anderson; Anthony W. Bannon; Clark A. Briggs; Jerry J. Buccafusco; Jorge D. Brioni; John B. Cannon; Michael W. Decker; Diana Donnelly‐Roberts; Murali Gopalakrishnan; Mark W. Holladay; Jaroslav Kyncl; Kennan C. Marsh; James Pauly; Richard J. Radek; A. David Rodrigues; James P. Sullivan

doi:10.1111/j.1527-3458.1995.tb00274.x

Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

Stephen P. Arneric
, David J. Anderson
, Anthony W. Bannon
, Clark A. Briggs
, Jerry J. Buccafusco
, Jorge D. Brioni
, John B. Cannon
, Michael W. Decker
, Diana Donnelly‐Roberts
, Murali Gopalakrishnan
, Mark W. Holladay
, Jaroslav Kyncl
, Kennan C. Marsh
, James Pauly
, Richard J. Radek
, A. David Rodrigues
, James P. Sullivan

Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Original language	English
Pages (from-to)	1-26
Number of pages	26
Journal	CNS Drug Reviews
Volume	1
Issue number	1
DOIs	https://doi.org/10.1111/j.1527-3458.1995.tb00274.x
State	Published - Mar 1995

Keywords

ABT‐418
Alzheimer's disease
cholinergic channel activator
cytoprotection
neuronal nicotinic acetylcholine receptor

ASJC Scopus subject areas

Neuropsychology and Physiological Psychology
Pharmacology

Access to Document

10.1111/j.1527-3458.1995.tb00274.x

Cite this

Arneric, S. P., Anderson, D. J., Bannon, A. W., Briggs, C. A., Buccafusco, J. J., Brioni, J. D., Cannon, J. B., Decker, M. W., Donnelly‐Roberts, D., Gopalakrishnan, M., Holladay, M. W., Kyncl, J., Marsh, K. C., Pauly, J., Radek, R. J., Rodrigues, A. D., & Sullivan, J. P. (1995). Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease. CNS Drug Reviews, 1(1), 1-26. https://doi.org/10.1111/j.1527-3458.1995.tb00274.x

@article{42a15149669d4a6885b2fb06b2bca1f9,

title = "Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease",

keywords = "ABT‐418, Alzheimer's disease, cholinergic channel activator, cytoprotection, neuronal nicotinic acetylcholine receptor",

author = "Arneric, \{Stephen P.\} and Anderson, \{David J.\} and Bannon, \{Anthony W.\} and Briggs, \{Clark A.\} and Buccafusco, \{Jerry J.\} and Brioni, \{Jorge D.\} and Cannon, \{John B.\} and Decker, \{Michael W.\} and Diana Donnelly‐Roberts and Murali Gopalakrishnan and Holladay, \{Mark W.\} and Jaroslav Kyncl and Marsh, \{Kennan C.\} and James Pauly and Radek, \{Richard J.\} and Rodrigues, \{A. David\} and Sullivan, \{James P.\}",

year = "1995",

month = mar,

doi = "10.1111/j.1527-3458.1995.tb00274.x",

language = "English",

volume = "1",

pages = "1--26",

number = "1",

}

Arneric, SP, Anderson, DJ, Bannon, AW, Briggs, CA, Buccafusco, JJ, Brioni, JD, Cannon, JB, Decker, MW, Donnelly‐Roberts, D, Gopalakrishnan, M, Holladay, MW, Kyncl, J, Marsh, KC, Pauly, J, Radek, RJ, Rodrigues, AD & Sullivan, JP 1995, 'Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease', CNS Drug Reviews, vol. 1, no. 1, pp. 1-26. https://doi.org/10.1111/j.1527-3458.1995.tb00274.x

TY - JOUR

T1 - Preclinical Pharmacology of ABT‐418

T2 - A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

AU - Arneric, Stephen P.

AU - Anderson, David J.

AU - Bannon, Anthony W.

AU - Briggs, Clark A.

AU - Buccafusco, Jerry J.

AU - Brioni, Jorge D.

AU - Cannon, John B.

AU - Decker, Michael W.

AU - Donnelly‐Roberts, Diana

AU - Gopalakrishnan, Murali

AU - Holladay, Mark W.

AU - Kyncl, Jaroslav

AU - Marsh, Kennan C.

AU - Pauly, James

AU - Radek, Richard J.

AU - Rodrigues, A. David

AU - Sullivan, James P.

PY - 1995/3

Y1 - 1995/3

KW - ABT‐418

KW - Alzheimer's disease

KW - cholinergic channel activator

KW - cytoprotection

KW - neuronal nicotinic acetylcholine receptor

UR - https://www.scopus.com/pages/publications/84989491045

UR - https://www.scopus.com/pages/publications/84989491045#tab=citedBy

U2 - 10.1111/j.1527-3458.1995.tb00274.x

DO - 10.1111/j.1527-3458.1995.tb00274.x

M3 - Article

AN - SCOPUS:84989491045

SN - 1080-563X

VL - 1

SP - 1

EP - 26

JO - CNS Drug Reviews

JF - CNS Drug Reviews

IS - 1

ER -

Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this